Clinical-stage medtech developing a non-surgical device for tricuspid regurgitation
| Date | Round | Amount |
|---|---|---|
| Jul 2025 | Grant Irish medtech CroiValve received EIC Accelerator funding (grant plus direct investment); CroiValve and Lios together secured EUR 18.75m. | — |
| Feb 2022 | Funding round Dublin medtech CroiValve raised €8m led by HBAN syndicates (with Elkstone, DBIC, SOSV) to fund a clinical study of its tricuspid valve device. | $8.6M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.